Economic consequences of idiopathic pulmonary fibrosis in Denmark

Ole Hilberg; Elisabeth Bendstrup; Rikke Ibsen; Anders Løkke; Charlotte Hyldgaard

doi:10.1183/23120541.00045-2017

Economic consequences of idiopathic pulmonary fibrosis in Denmark

Ole Hilberg, Elisabeth Bendstrup, Rikke Ibsen, Anders Løkke, Charlotte Hyldgaard

IRS - Sygehus Lillebælt

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

28 Downloads (Pure)

Abstract

When a patient is diagnosed with IPF, the net health costs increase from €2753 to €21 184 per year even without the cost of antifibrotic treatment. Inpatient treatment accounts for the main part of the expenses http://ow.ly/dSsn30jEx0p.

Originalsprog	Engelsk
Tidsskrift	ERJ Open Research
Vol/bind	4
Udgave nummer	2
Antal sider	4
ISSN	2312-0541
DOI	https://doi.org/10.1183/23120541.00045-2017
Status	Udgivet - apr. 2018

Dokumenter og links

10.1183/23120541.00045-2017Licens: CC BY-NC

Open access versionForlagets udgivne version, 337 KBLicens: CC BY-NC

Citationsformater

@article{9ba9b5714bb04fa4bf04561d7a00705d,

title = "Economic consequences of idiopathic pulmonary fibrosis in Denmark",

abstract = "When a patient is diagnosed with IPF, the net health costs increase from €2753 to €21 184 per year even without the cost of antifibrotic treatment. Inpatient treatment accounts for the main part of the expenses http://ow.ly/dSsn30jEx0p.",

author = "Ole Hilberg and Elisabeth Bendstrup and Rikke Ibsen and Anders L{\o}kke and Charlotte Hyldgaard",

year = "2018",

month = apr,

doi = "10.1183/23120541.00045-2017",

language = "English",

volume = "4",

journal = "ERJ Open Research",

issn = "2312-0541",

publisher = "ERS publications",

number = "2",

}

TY - JOUR

T1 - Economic consequences of idiopathic pulmonary fibrosis in Denmark

AU - Hilberg, Ole

AU - Bendstrup, Elisabeth

AU - Ibsen, Rikke

AU - Løkke, Anders

AU - Hyldgaard, Charlotte

PY - 2018/4

Y1 - 2018/4

N2 - When a patient is diagnosed with IPF, the net health costs increase from €2753 to €21 184 per year even without the cost of antifibrotic treatment. Inpatient treatment accounts for the main part of the expenses http://ow.ly/dSsn30jEx0p.

AB - When a patient is diagnosed with IPF, the net health costs increase from €2753 to €21 184 per year even without the cost of antifibrotic treatment. Inpatient treatment accounts for the main part of the expenses http://ow.ly/dSsn30jEx0p.

U2 - 10.1183/23120541.00045-2017

DO - 10.1183/23120541.00045-2017

M3 - Comment/debate

C2 - 29850467

SN - 2312-0541

VL - 4

JO - ERJ Open Research

JF - ERJ Open Research

IS - 2

ER -

Economic consequences of idiopathic pulmonary fibrosis in Denmark

Abstract

Dokumenter og links

Fingeraftryk

Citationsformater